108 related articles for article (PubMed ID: 10792128)
21. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives.
Chimenti F; Bizzarri B; Manna F; Bolasco A; Secci D; Chimenti P; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
Bioorg Med Chem Lett; 2005 Feb; 15(3):603-7. PubMed ID: 15664821
[TBL] [Abstract][Full Text] [Related]
22. ORAC and DPPH assay comparison to assess antioxidant capacity of tea infusions: relationship between total polyphenol and individual catechin content.
Roy MK; Koide M; Rao TP; Okubo T; Ogasawara Y; Juneja LR
Int J Food Sci Nutr; 2010 Mar; 61(2):109-24. PubMed ID: 20109129
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate on mouse type IV allergy.
Suzuki M; Yoshino K; Maeda-Yamamoto M; Miyase T; Sano M
J Agric Food Chem; 2000 Nov; 48(11):5649-53. PubMed ID: 11087533
[TBL] [Abstract][Full Text] [Related]
24. The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase.
Wang X; Song KS; Guo QX; Tian WX
Biochem Pharmacol; 2003 Nov; 66(10):2039-47. PubMed ID: 14599562
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus.
Zhao WH; Hu ZQ; Hara Y; Shimamura T
Antimicrob Agents Chemother; 2002 Jul; 46(7):2266-8. PubMed ID: 12069986
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria.
Ani AE; Malu AO; Onah JA; Queiroz DM; Kirschner G; Rocha GA
Trans R Soc Trop Med Hyg; 1999; 93(6):659-61. PubMed ID: 10717760
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of New Nitrofluoroquinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant H. pylori.
Abu-Qatouseh L; Abu-Sini M; Mayyas A; Al-Hiari Y; Darwish R; Aburjai T
Molecules; 2017 Jan; 22(1):. PubMed ID: 28054994
[TBL] [Abstract][Full Text] [Related]
28. Anti-Helicobacter pylori activity of the metabolites of poncirin from Poncirus trifoliata by human intestinal bacteria.
Kim DH; Bae EA; Han MJ
Biol Pharm Bull; 1999 Apr; 22(4):422-4. PubMed ID: 10328566
[TBL] [Abstract][Full Text] [Related]
29. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate.
Yoda Y; Hu ZQ; Zhao WH; Shimamura T
J Infect Chemother; 2004 Feb; 10(1):55-8. PubMed ID: 14991521
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Glupczynski Y; Broutet N; Cantagrel A; Andersen LP; Alarcon T; López-Brea M; Mégraud F
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):549-52. PubMed ID: 12172749
[TBL] [Abstract][Full Text] [Related]
31. Interaction of tea catechins with lipid bilayers investigated with liposome systems.
Hashimoto T; Kumazawa S; Nanjo F; Hara Y; Nakayama T
Biosci Biotechnol Biochem; 1999 Dec; 63(12):2252-5. PubMed ID: 10664864
[TBL] [Abstract][Full Text] [Related]
32. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
Moshafi MH; Sorkhi M; Emami S; Nakhjiri M; Yahya-Meymandi A; Negahbani AS; Siavoshi F; Omrani M; Alipour E; Vosooghi M; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2011 Mar; 344(3):178-83. PubMed ID: 21384417
[TBL] [Abstract][Full Text] [Related]
33.
Xu YF; Lian DW; Chen YQ; Cai YF; Zheng YF; Fan PL; Ren WK; Fu LJ; Li YC; Xie JH; Cao HY; Tan B; Su ZR; Huang P
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320722
[TBL] [Abstract][Full Text] [Related]
34. Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin.
Baffone W; Pianetti A; Citterio B; Lombardelli G; Vittoria E; Bruscolini F
J Chemother; 2001 Apr; 13(2):126-32. PubMed ID: 11330358
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568
[TBL] [Abstract][Full Text] [Related]
36. [Antibacterial and anti-hemolysin activities of tea catechins and their structural relatives].
Toda M; Okubo S; Ikigai H; Shimamura T
Nihon Saikingaku Zasshi; 1990 Mar; 45(2):561-6. PubMed ID: 2381042
[TBL] [Abstract][Full Text] [Related]
37. In vitro antagonism of rabeprazole and metronidazole upon clinical isolates of Helicobacter pylori.
Soto A; García A; González CL
Chemotherapy; 2009; 55(5):308-11. PubMed ID: 19556788
[TBL] [Abstract][Full Text] [Related]
38. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
Phillips K; Munster DJ; Allardyce RA; Bagshaw PF
J Clin Pathol; 1993 Apr; 46(4):372-3. PubMed ID: 8496397
[TBL] [Abstract][Full Text] [Related]
40. In vitro cytotoxicity of (-)-catechin gallate, a minor polyphenol in green tea.
Babich H; Zuckerbraun HL; Weinerman SM
Toxicol Lett; 2007 Jul; 171(3):171-80. PubMed ID: 17606338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
